AMALGAMATED BANK - 4D MOLECULAR THERAPEUTICS IN ownership

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 94 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$50
-15.3%
3,904
+20.0%
0.00%
Q2 2023$59
+7.3%
3,252
+2.5%
0.00%
Q1 2023$55
-34.5%
3,172
-16.2%
0.00%
-100.0%
Q4 2022$84
-99.7%
3,787
+2.4%
0.00%
Q3 2022$30,000
+15.4%
3,6970.0%0.00%
Q2 2022$26,000
-50.9%
3,697
+5.8%
0.00%
Q1 2022$53,0003,4950.00%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 1,566,895$23,691,0005.12%
Aquilo Capital Management, LLC 1,755,506$26,543,0003.90%
Deep Track Capital, LP 2,448,200$37,017,0002.37%
BVF INC/IL 2,664,521$40,288,0001.61%
Opaleye Management Inc. 325,000$4,914,0001.53%
Perigon Wealth Management, LLC 557,475$8,429,0000.60%
Eagle Health Investments LP 132,090$1,997,0000.49%
Casdin Capital, LLC 555,455$8,398,0000.38%
VIKING GLOBAL INVESTORS LP 3,937,914$59,541,0000.24%
ArrowMark Colorado Holdings LLC 1,145,585$17,321,0000.15%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders